ARTICLE | Clinical News
Immunomedics preclinical data
June 24, 2002 7:00 AM UTC
IMMU said its method of labeling hRS7 with I-131 delivered 4 times the dose of radiation to breast cancer tumors compared to the same antibody labeled with I-131 using conventional methods. The increa...